BDBM50344827 1-(4-chlorobenzyl)-3-(3,4-dihydro-2H-benzo[b][1,4]dioxepin-7-yl)-3-hydroxyindolin-2-one::CHEMBL1779928

SMILES OC1(C(=O)N(Cc2ccc(Cl)cc2)c2ccccc12)c1ccc2OCCCOc2c1

InChI Key InChIKey=YIIWSLXLWPRZFT-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50344827   

TargetSodium channel protein type 9 subunit alpha(Human)
Xenon Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50344827(1-(4-chlorobenzyl)-3-(3,4-dihydro-2H-benzo[b][1,4]...)
Affinity DataIC50: 3.21E+3nMAssay Description:Inhibition of human NaV1.7 expressed in HEK293 cells by [14C]guanidinium influx assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2011
Entry Details Article
PubMed